BELLICUM PHARMACEUTICALS, INC Annual Operating Income (Loss) in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2022.
  • Bellicum Pharmaceuticals, Inc Operating Income (Loss) for the quarter ending September 30, 2023 was -$773K, a 89.2% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc Operating Income (Loss) for the twelve months ending September 30, 2023 was -$23.8M, a 3.7% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2022 was -$27M, a 8.51% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2021 was -$24.9M, a 51.9% increase from 2020.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2020 was -$51.7M, a 40.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$27M -$2.12M -8.51% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$24.9M +$26.8M +51.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$51.7M +$35.7M +40.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$87.4M +$8.1M +8.49% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$95.5M -$8.08M -9.25% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$87.4M -$19M -27.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$68.4M -$19.2M -39.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 -$49.1M +$8.7M +15% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$57.8M -$49.9M -630% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 -$7.92M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.